Kestra Medical (KMTS) CEO Brian Webster Sells Shares

What Happened
Brian Daniel Webster, President and Chief Executive Officer of Kestra Medical Technologies (KMTS), disposed of a total of 29,822 common shares via open-market sales between July 30 and August 3, 2026. The three transactions generated aggregate proceeds of approximately $692,215. These sales were reported as nondiscretionary "sell-to-cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

Key Details

• Transactions:
  • 2026-07-30: Sold 7,857 shares at a weighted average price of $22.72; proceeds $178,531. (Price range reported: $22.2524–$23.1700) [F2]
  • 2026-07-31: Sold 8,948 shares at a weighted average price of $22.60; proceeds $202,260. (Price range reported: $22.0577–$22.9200) [F3]
  • 2026-08-03: Sold 13,017 shares at a weighted average price of $23.92; proceeds $311,424. (Price range reported: $23.6400–$24.1100) [F4]
• Total shares sold: 29,822; total proceeds: ~$692,215.
• Reason noted: Nondiscretionary sell-to-cover to satisfy tax withholding for RSU vesting. [F1]
• Shares owned after the transactions: not specified in the provided excerpt of the Form 4.
• Filing: Form 4 was filed on 2026-08-03; the filing appears timely for the reported transaction dates.

Context

• These sales were described as tax-withholding “sell-to-cover” related to RSU settlement—routine administrative transactions that do not necessarily signal the insider’s view of the company's prospects. Purchases or increases in holdings are typically more indicative of insider bullishness.